ScholarIQanswers from OpenAlex & ORCID
J. Jan B. van Lanschot
ResearcherPublications, citations & collaboration network
J. Jan B. van Lanschot is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does J. Jan B. van Lanschot have?
ScholarIQindexed works
J. Jan B. van Lanschot has 320 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does J. Jan B. van Lanschot have?
ScholarIQcitation count
J. Jan B. van Lanschot has 28,905 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of J. Jan B. van Lanschot?
ScholarIQh-index
J. Jan B. van Lanschot has an h-index of 71 in OpenAlex.
What is the i10-index of J. Jan B. van Lanschot?
ScholarIQi10-index
J. Jan B. van Lanschot has an i10-index of 192 in OpenAlex.
What is the ORCID of J. Jan B. van Lanschot?
ScholarIQorcid
The ORCID for J. Jan B. van Lanschot is on the source record.
What is the OpenAlex record for J. Jan B. van Lanschot?
ScholarIQopenalex
The OpenAlex for J. Jan B. van Lanschot is on the source record.
What are the most-cited papers on J. Jan B. van Lanschot?
ScholarIQmost cited works
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
Pieter van Hagen, Maarten C.C.M. Hulshof, J. Jan B. van Lanschot, Ewout W. Steyerberg, Mark I. van Berge Henegouwen, Bas P. L. Wijnhoven, Dick J. Richel, Grard A. P. Nieuwenhuijzen, Geke A.P. Hospers, Johannes J. Bonenkamp, Miguel A. Cuesta, R.J.B. Blaisse, Olivier R. Busch, F.J.W. ten Kate, G.J. Creemers, C.J.A. Punt, John Theodorus Plukker, Henk M.W. Verheul, Ernst Jan Spillenaar Bilgen, Herman van Dekken, Maurice J.C. van der Sangen, Tom Rozema, Katharina Biermann, Jannet C. Beukema, Anna H.M. Piet, Caroline M. van Rij, Janny G. Reinders, H.W. Tilanus, Ate van der Gaast
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof, Pieter van Hagen, Mark I. van Berge Henegouwen, Bas P. L. Wijnhoven, Hanneke W.M. van Laarhoven, Grard A. P. Nieuwenhuijzen, Geke A.P. Hospers, Johannes J. Bonenkamp, Miguel A. Cuesta, R.J.B. Blaisse, Olivier R. Busch, Fiebo J.W. ten Kate, Geert-Jan Creemers, Cornelis J.A. Punt, John Th. M. Plukker, Henk M.W. Verheul, Ernst Jan Spillenaar Bilgen, Herman van Dekken, Maurice J.C. van der Sangen, Tom Rozema, Katharina Biermann, Jannet C. Beukema, Anna H.M. Piet, Caroline M. van Rij, Janny G. Reinders, Hugo W. Tilanus, Ewout W. Steyerberg, Ate van der Gaast
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
Jan B.F. Hulscher, Johanna W. van Sandick, Angela G. E. M. de Boer, Bas P. L. Wijnhoven, Jan G.P. Tijssen, Paul Fockens, Peep F. M. Stalmeier, Fiebo J.W. ten Kate, Herman van Dekken, H. Obertop, Hugo W. Tilanus, J. Jan B. van Lanschot
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
Ben M. Eyck, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof, Berend J. van der Wilk, Joël Shapiro, Pieter van Hagen, Mark I. van Berge Henegouwen, Bas P. L. Wijnhoven, Hanneke W. M. van Laarhoven, Grard A. P. Nieuwenhuijzen, Geke A.P. Hospers, Johannes J. Bonenkamp, Miguel A. Cuesta, R.J.B. Blaisse, Olivier R. Busch, Geert-Jan Creemers, Cornelis J.A. Punt, John Th. M. Plukker, Henk M.W. Verheul, Ernst Jan Spillenaar Bilgen, Maurice J.C. van der Sangen, Tom Rozema, Fiebo J.W. ten Kate, Jannet C. Beukema, Anna H.M. Piet, Caroline M. van Rij, Janny G. Reinders, Hugo W. Tilanus, Ewout W. Steyerberg, Ate van der Gaast, for the CROSS Study Group
Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus
Jikke M.T. Omloo, Sjoerd M. Lagarde, Jan B.F. Hulscher, Johannes B. Reitsma, Paul Fockens, Herman van Dekken, Fiebo J.W. ten Kate, H. Obertop, Hugo W. Tilanus, J. Jan B. van Lanschot